KLOW is a single 80 mg lyophilized vial containing four compounds: GHK-Cu, BPC-157, TB-500 and KPV. GHK-Cu is the predominant component; exact proportions for the vial you receive are printed on that lot's certificate of analysis.

Each component is assayed by HPLC-UV at 220 nm for purity under USP , identity is confirmed by FTIR under USP , and bacterial endotoxin is measured by gel-clot LAL under USP . Testing is performed by an accredited third-party laboratory, not in house.

Why are these four compounds combined?

Each has been studied in a different part of the matrix-remodelling and inflammatory-signalling literature — copper transport and matrix remodelling, angiogenic and gastrointestinal models, actin sequestration, and melanocortin-pathway inflammatory signalling. Combining them into one vial is a formulation convenience for researchers designing multi-component protocols; it is not evidence of a combined effect.

Is KLOW for human use?

No. KLOW is supplied for research use only and is not for human or veterinary use.

Sequence	GHK-Cu · BPC-157 · TB-500 · KPV
Length	4-component blend
Formula	Multi-component
Mol. weight	Aggregate
CAS	N/A
PubChem	N/A

Multi-Compound Blend

KLOW

KLOW is a multi-compound blend combining GHK-Cu, BPC-157, TB-500 fragment, and KPV in a single 80 mg lyophilized formulation. The blend is supplied for comprehensive multi-component study designs.

Molecular structure

A blend has no single structure, so each component is set out on its own. Masses are for the individual compounds, not the blended fill weight.

GHK-CuCopper tripeptide-1

Gly

His

Lys

C₁₄H₂₃N₆O₄Cu, 402.93 g/mol

The glycyl-L-histidyl-L-lysine tripeptide bound to a copper(II) ion.

BPC-157Pentadecapeptide

Gly

Glu

Pro

Gly

Lys

Pro

Ala

Asp

Ala

Gly

Leu

Val

C₆₂H₉₈N₁₆O₂₂, 1419.56 g/mol

Fifteen residues corresponding to a partial sequence identified in human gastric juice.

TB-500Thymosin beta-4 fragment, acetylated

Leu

Lys

Thr

Glu

Thr

Gln

C₃₈H₆₈N₁₀O₁₄, 889.02 g/mol

The seven residue actin binding region of thymosin beta-4.

KPVTripeptide

Lys

Pro

Val

C₁₆H₃₀N₄O₄, 342.44 g/mol

The C terminal tripeptide of alpha-melanocyte stimulating hormone.

Back to KLOW

For Research Use Only. Not for human or veterinary use.